EIKN ▲ +0.1% - Eikon Therapeutics, Inc.
$EIKN - Eikon Therapeutics Submits IND for Novel Androgen Receptor Antagonist EIK1006 in Prostate Cancer
15-OCT-2026 08:00 AM ET
Share this post
More filings for $EIKN
EIKN - Eikon Therapeutics, Inc. - SEC Filing Update (07-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 7, 2026EIKN - Eikon Therapeutics, Inc. - SEC Filing Update (02-OCT-2026) | ThinkSabio - Stocks SimplifiedOct 2, 2026EIKN ▼ -1.5% - Eikon Therapeutics, Inc.Sep 3, 2026EIKN - Eikon Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 6, 2026
View full $EIKN filing history →💬 Comments
Loading comments…
Leave a comment